How does Viking’s weight loss med compare to ones from Novo, Eli Lilly?

Overweight man emptying large pill from pill bottle

Jon Feingersh Photography Inc/DigitalVision via Getty Images

Data reported earlier Monday from Viking Therapeutics (NASDAQ:VKTX) on its weight loss medicine VK2735 indicates that Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY), which currently dominate the obesity drug space, could face competition.

VK2735, which is being developed in both as

Leave a Reply

Your email address will not be published. Required fields are marked *